4//SEC Filing
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 4
Accession 0000902664-24-000903
CIK 0001868279other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:47 PM ET
Size
18.4 KB
Accession
0000902664-24-000903
Insider Transaction Report
Form 4
Hillhouse Capital Management, Ltd.
10% Owner
Transactions
- Conversion
Common Stock
2024-01-30+3,616,041→ 3,616,041 total(indirect: See footnotes) - Conversion
Common Stock
2024-01-30+313,076→ 3,929,117 total(indirect: See footnotes) - Conversion
Series A Preferred Stock
2024-01-30−55,000,000→ 0 total(indirect: See footnotes)→ Common Stock (3,616,041 underlying) - Purchase
Common Stock
2024-01-30$18.00/sh+555,555$9,999,990→ 4,484,672 total(indirect: See footnotes) - Conversion
Series B Preferred Stock
2024-01-30−4,761,903→ 0 total(indirect: See footnotes)→ Common Stock (313,076 underlying)
Footnotes (6)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis.
- [F2]The securities reported herein are held by VSUM VI Holdings Limited ("VSUM VI") and VSUM VIII Holdings Limited ("VSUM VIII"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. ("Hillhouse Venture V") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. ("Hillhouse Healthcare"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare.
- [F3]The securities reported herein are held by VSUM VIII and ARVT Holdings Limited ("ARVT"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. ("Hillhouse Venture VI"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI.
- [F4]The securities reported herein are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership ("HHLR Fund"). HHLR (as defined below) acts as the sole management company of HHLR Fund.
- [F5]This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company ("HIM") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company ("HHLR"). The foregoing persons are hereinafter sometimes each referred to as a "Reporting Person" and collectively referred to as the "Reporting Persons." HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly.
- [F6]The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.
Documents
Issuer
ArriVent Biopharma, Inc.
CIK 0001868279
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001510589
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:47 PM ET
- Size
- 18.4 KB